These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29523334)

  • 1. The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis.
    Korkegian A; O'Malley T; Xia Y; Zhou Y; Carter DS; Sunde B; Flint L; Thompson D; Ioerger TR; Sacchettini J; Alley MRK; Parish T
    Tuberculosis (Edinb); 2018 Jan; 108():96-98. PubMed ID: 29523334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
    Zhang YK; Plattner JJ; Freund YR; Easom EE; Zhou Y; Ye L; Zhou H; Waterson D; Gamo FJ; Sanz LM; Ge M; Li Z; Li L; Wang H; Cui H
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1299-307. PubMed ID: 22243961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis
    Patel N; O'Malley T; Zhang YK; Xia Y; Sunde B; Flint L; Korkegian A; Ioerger TR; Sacchettini J; Alley MRK; Parish T
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3.
    Remuiñán MJ; Pérez-Herrán E; Rullás J; Alemparte C; Martínez-Hoyos M; Dow DJ; Afari J; Mehta N; Esquivias J; Jiménez E; Ortega-Muro F; Fraile-Gabaldón MT; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Minick DJ; Cacho M; Rebollo-López MJ; González C; Sousa V; Angulo-Barturen I; Mendoza-Losana A; Barros D; Besra GS; Ballell L; Cammack N
    PLoS One; 2013; 8(4):e60933. PubMed ID: 23613759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic lethality of
    Xu Y; Ehrt S; Schnappinger D; Beites T
    mBio; 2023 Dec; 14(6):e0104523. PubMed ID: 38032200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
    Lee AS; Teo AS; Wong SY
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2157-9. PubMed ID: 11408244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro.
    Awasthy D; Ambady A; Narayana A; Morayya S; Sharma U
    Gene; 2014 Oct; 550(1):110-6. PubMed ID: 25128581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of ndh gene of isoniazid resistant and susceptible Mycobacterium tuberculosis isolates from Brazil.
    Cardoso RF; Cardoso MA; Leite CQ; Sato DN; Mamizuka EM; Hirata RD; de Mello FF; Hirata MH
    Mem Inst Oswaldo Cruz; 2007 Feb; 102(1):59-61. PubMed ID: 17294000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.
    Baker SJ; Zhang YK; Akama T; Lau A; Zhou H; Hernandez V; Mao W; Alley MR; Sanders V; Plattner JJ
    J Med Chem; 2006 Jul; 49(15):4447-50. PubMed ID: 16854048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
    McNeil MB; O'Malley T; Dennison D; Shelton CD; Sunde B; Parish T
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.
    Sellamuthu S; Singh M; Kumar A; Singh SK
    Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Tethering' fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase.
    Heikal A; Nakatani Y; Jiao W; Wilson C; Rennison D; Weimar MR; Parker EJ; Brimble MA; Cook GM
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2239-2243. PubMed ID: 29859905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of tavaborole for the treatment of onychomycosis.
    Gupta AK; Daigle D
    Future Microbiol; 2014; 9(11):1243-50. PubMed ID: 25437186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity of
    Vilchèze C; Weinrick B; Leung LW; Jacobs WR
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1599-1604. PubMed ID: 29382761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines.
    Schurig-Briccio LA; Yano T; Rubin H; Gennis RB
    Biochim Biophys Acta; 2014 Jul; 1837(7):954-63. PubMed ID: 24709059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1
    Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and evaluation of benzodiazaborine compounds against M. tuberculosis H37Rv in vitro.
    Davis MC; Franzblau SG; Martin AR
    Bioorg Med Chem Lett; 1998 Apr; 8(7):843-6. PubMed ID: 9871552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.